Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming conferences. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website: www.arraybiopharma.com.
|Event:||Stifel Nicolaus Healthcare Conference|
|Date:||Thursday, September 6, 2012|
|Time:||9:45 a.m. Eastern Time|
|Location:||Four Seasons, Boston, MA|
|Event:||NewsMakers in the Biotech Industry Conference|
|Date:||Friday, September 7, 2012|
|Time:||8:30 a.m. Eastern Time|
|Location:||Millennium Broadway Hotel, New York, NY|
|Event:||Morgan Stanley Global Healthcare Conference|
|Date:||Monday, September 10. 2012|
|Time:||10:35 a.m. Eastern Time|
|Location:||Grand Hyatt, New York, NY|
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small-molecule
drugs to treat patients afflicted with cancer. Array is evolving into a
late-stage development company, with two wholly-owned programs, ARRY-614
and ARRY-520, and three partnered programs, selumetinib partnered with
AstraZeneca, MEK162 partnered with Novartis, and danoprevir, partnered
with InterMune / Roche, having the potential to begin Phase 3 or pivotal
trials by the end of calendar year 2013. For more information on Array,
please go to
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV